CY1317A - Tallysomycin compounds - Google Patents

Tallysomycin compounds

Info

Publication number
CY1317A
CY1317A CY1317A CY131780A CY1317A CY 1317 A CY1317 A CY 1317A CY 1317 A CY1317 A CY 1317A CY 131780 A CY131780 A CY 131780A CY 1317 A CY1317 A CY 1317A
Authority
CY
Cyprus
Prior art keywords
tallysomycin
compounds
tallysomycin compounds
Prior art date
Application number
CY1317A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CY1317A publication Critical patent/CY1317A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY1317A 1979-07-13 1980-07-11 Tallysomycin compounds CY1317A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/057,528 US4246400A (en) 1979-07-13 1979-07-13 Tallysomycin compounds

Publications (1)

Publication Number Publication Date
CY1317A true CY1317A (en) 1986-03-28

Family

ID=22011128

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1317A CY1317A (en) 1979-07-13 1980-07-11 Tallysomycin compounds

Country Status (26)

Country Link
US (1) US4246400A (xx)
JP (1) JPS5659793A (xx)
AU (1) AU533469B2 (xx)
BE (1) BE884291A (xx)
CA (1) CA1144494A (xx)
CH (1) CH646982A5 (xx)
CY (1) CY1317A (xx)
DE (1) DE3026425A1 (xx)
DK (1) DK151633C (xx)
ES (1) ES493350A0 (xx)
FI (1) FI67876C (xx)
FR (1) FR2460961A1 (xx)
GB (1) GB2053221B (xx)
GR (1) GR82324B (xx)
HK (1) HK8286A (xx)
IE (1) IE50020B1 (xx)
IL (1) IL60541A (xx)
IT (1) IT1174296B (xx)
LU (1) LU82612A1 (xx)
MY (1) MY8800097A (xx)
NL (1) NL8003970A (xx)
NO (1) NO155701C (xx)
NZ (1) NZ193921A (xx)
SE (1) SE449751B (xx)
YU (1) YU43218B (xx)
ZA (1) ZA804150B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058838A1 (en) * 1981-02-23 1982-09-01 American Cyanamid Company Antibiotic LL BO1208 alpha and LL BO1208 beta
US4650765A (en) * 1981-02-23 1987-03-17 American Cyanamid Company Biologically pure culture of Streptoverticillium stramineum sp. nov.
JPH02267083A (ja) * 1989-04-07 1990-10-31 Nissan Motor Co Ltd 自動車のフロントボデー補強構造
US5420228A (en) * 1991-04-05 1995-05-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Fluorescent-labelled bleomycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038242A (en) * 1963-03-05 1966-08-10 Zaidan Hojin Biseibutsu Bleomycin and processes for preparation thereof
GB1292081A (en) * 1969-02-15 1972-10-11 Zaidan Hojin Biseibutsu Process for producing bleomycin antibiotics
US3846400A (en) * 1969-02-15 1974-11-05 Microbial Chem Res Found Novel process for producing antibiotics bleomycin
US3814796A (en) * 1969-10-09 1974-06-04 Upjohn Co Antibiotics zorbonomycin and zorbonomycin b and process for the preparation thereof
US3922262A (en) * 1971-04-28 1975-11-25 Nippon Kayaku Kk N-Substituted derivatives of bleomycins
JPS5739751B2 (xx) * 1972-03-03 1982-08-23
US4051237A (en) * 1975-08-28 1977-09-27 Bristol-Myers Company Glycopeptide antibiotics bu-2231 a and b and process for producing same
US4195018A (en) * 1977-07-01 1980-03-25 Nippon Kayaku Kabushiki Kaisha 3-[(S)-1'-Phenylethylamino]propylaminobleomycin, non-toxic salt thereof, and method for producing same

Also Published As

Publication number Publication date
NZ193921A (en) 1982-09-14
HK8286A (en) 1986-02-14
YU143580A (en) 1983-04-30
NL8003970A (nl) 1981-01-15
ZA804150B (en) 1981-07-29
CA1144494A (en) 1983-04-12
JPS6328080B2 (xx) 1988-06-07
AU533469B2 (en) 1983-11-24
FR2460961A1 (fr) 1981-01-30
ES8106554A1 (es) 1981-07-01
GB2053221A (en) 1981-02-04
DK297980A (da) 1981-01-14
BE884291A (fr) 1981-01-12
AU5919080A (en) 1981-01-15
LU82612A1 (fr) 1981-02-02
IT1174296B (it) 1987-07-01
IL60541A (en) 1983-12-30
IE801444L (en) 1981-01-13
FI67876B (fi) 1985-02-28
CH646982A5 (fr) 1984-12-28
MY8800097A (en) 1988-12-31
NO155701B (no) 1987-02-02
JPS5659793A (en) 1981-05-23
ES493350A0 (es) 1981-07-01
DK151633B (da) 1987-12-21
DK151633C (da) 1988-06-20
NO802048L (no) 1981-01-14
US4246400A (en) 1981-01-20
IT8049183A0 (it) 1980-07-07
DE3026425C2 (xx) 1989-11-09
GB2053221B (en) 1983-05-05
FR2460961B1 (xx) 1983-11-18
IL60541A0 (en) 1980-09-16
SE449751B (sv) 1987-05-18
SE8005134L (sv) 1981-01-14
GR82324B (xx) 1984-12-13
DE3026425A1 (de) 1981-01-29
NO155701C (no) 1987-05-13
IE50020B1 (en) 1986-02-05
FI67876C (fi) 1985-06-10
FI802198A (fi) 1981-01-14
YU43218B (en) 1989-06-30

Similar Documents

Publication Publication Date Title
GB2052478B (en) Guanidinothiazole compounds
JPS5594363A (en) Phenoxyphenylpiperidine compound
JPS5610183A (en) 199hydroxyypgi compound
JPS5686134A (en) Eicosapentanoate compound
IL59287A0 (en) 14-methoxymorphinan-6-one compounds
JPS55124743A (en) 99aminoalkylfluorene compound
JPS56113779A (en) Compound
GB2125037B (en) 2-acetoxymethyl-penam compounds
ZA806146B (en) Heterocyclici compounds
JPS5667369A (en) Phthaloperinone compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
GB2053221B (en) Tallysomycin compounds
JPS55113769A (en) 44substitutedd22iminoimidazolidine compound
ZA802765B (en) Novel compounds
GB2047708B (en) Butyloctyl-magnesium compounds
IL61133A0 (en) 6-methylene-morphinan compounds
JPS55136264A (en) Pyridineacetoamide compound
ZA807948B (en) 2-oxybenzimidazoline compounds
JPS5632575A (en) Antiifreeze compound
JPS56100858A (en) Halootriazinyl compound
DE3064156D1 (en) 1-halo-4-decene compounds
GB2111983B (en) Cyclopent-4-en-5-olone compounds
JPS55162734A (en) 11aamethanootxa compounds
JPS5655333A (en) Ketoodiphenol compound
JPS55111487A (en) Furochromone compound